Suppr超能文献

葡萄糖转运调节两步模型的进一步证据。肌醇磷酸寡糖调节葡萄糖载体活性。

Further evidence for a two-step model of glucose-transport regulation. Inositol phosphate-oligosaccharides regulate glucose-carrier activity.

作者信息

Obermaier-Kusser B, Mühlbacher C, Mushack J, Seffer E, Ermel B, Machicao F, Schmidt F, Häring H U

机构信息

Institut für Diabetesforschung, München, Federal Republic of Germany.

出版信息

Biochem J. 1989 Aug 1;261(3):699-705. doi: 10.1042/bj2610699.

Abstract

The insulin effect on glucose uptake is not sufficiently explained by a simple glucose-carrier translocation model. Recent studies rather suggest a two-step model of carrier translocation and carrier activation. We used several pharmacological tools to characterize the proposed model further. We found that inositol phosphate (IP)-oligosaccharides isolated from the drug Actovegin, as well as the alkaloid vinblastine, show a partial insulin-like effect on glucose-transport activity of fat-cells (3-O-methylglucose uptake, expressed as % of equilibrium value per 4 s: basal 5.8%, insulin 59%, IP-oligosaccharides 30%, vinblastine 29%) without inducing carrier translocation. On the other hand, two newly developed anti-diabetic compounds (alpha-activated carbonic acids, BM 130795 and BM 13907) induced carrier translocation to the same extent as insulin and phorbol esters [cytochalasin-B-binding sites in plasma membranes: basal 5 pmol/mg of protein, insulin 13 pmol/mg of protein, TPA (12-O-tetradecanoylphorbol 13-acetate) 11.8 pmol/mg of protein, BM 130795 10.8 pmol/mg of protein], but produce also only 40-50% of the insulin effect on glucose-transport activity (basal 5.8%, insulin 59%, TPA 23%, BM 130795 35%). Almost the full insulin effect was mimicked by a combination of phorbol esters and IP-oligosaccharides (basal 7%, insulin 50%, IP-oligosaccharides 30%, TPA 23%, IP-oligosaccharides + TPA 45%). None of these substances stimulated insulin-receptor kinase in vitro or in vivo, suggesting a post-kinase site of action. The data confirm the following aspects of the proposed model: (1) carrier translocation and carrier activation are two independently regulated processes; (2) the full insulin effect is mimicked only by a simultaneous stimulation of carrier translocation and intrinsic carrier activity, suggesting that insulin acts through a synergism of both mechanisms; (3) IP-oligosaccharides might be involved in the transmission of a stimulatory signal on carrier activity.

摘要

简单的葡萄糖载体易位模型不足以解释胰岛素对葡萄糖摄取的作用。最近的研究反而提出了一个载体易位和载体激活的两步模型。我们使用了几种药理学工具来进一步描述所提出的模型。我们发现,从药物Actovegin中分离出的肌醇磷酸(IP)-寡糖以及生物碱长春花碱,对脂肪细胞的葡萄糖转运活性显示出部分胰岛素样作用(3-O-甲基葡萄糖摄取,以每4秒平衡值的百分比表示:基础值5.8%,胰岛素59%,IP-寡糖30%,长春花碱29%),但不会诱导载体易位。另一方面,两种新开发的抗糖尿病化合物(α-活化碳酸,BM 130795和BM 13907)诱导载体易位的程度与胰岛素和佛波酯相同[质膜中的细胞松弛素-B结合位点:基础值5 pmol/mg蛋白质,胰岛素13 pmol/mg蛋白质,TPA(12-O-十四烷酰佛波醇13-乙酸酯)11.8 pmol/mg蛋白质,BM 130795 10.8 pmol/mg蛋白质],但对葡萄糖转运活性的作用也仅为胰岛素作用的40 - 50%(基础值5.8%,胰岛素59%,TPA 23%,BM 130795 35%)。佛波酯和IP-寡糖的组合几乎模拟了完整的胰岛素作用(基础值7%,胰岛素50%,IP-寡糖30%,TPA 23%,IP-寡糖 + TPA 45%)。这些物质在体外或体内均未刺激胰岛素受体激酶,提示作用位点在激酶之后。数据证实了所提出模型的以下几个方面:(1)载体易位和载体激活是两个独立调节的过程;(2)只有同时刺激载体易位和内在载体活性才能模拟完整的胰岛素作用,这表明胰岛素通过这两种机制的协同作用发挥作用;(3)IP-寡糖可能参与了对载体活性的刺激信号传递。

相似文献

引用本文的文献

4
Actovegin®: a biological drug for more than 5 decades.爱维治®:一种已应用超过50年的生物药物。
Wien Med Wochenschr. 2011 Feb;161(3-4):80-8. doi: 10.1007/s10354-011-0865-y.

本文引用的文献

9
Microtubules.微管
Annu Rev Biochem. 1973;42:507-40. doi: 10.1146/annurev.bi.42.070173.002451.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验